Selected article for: "early study and significant difference"
Author: Bein, Thomas; Grasso, Salvatore; Moerer, Onnen; Quintel, Michael; Guerin, Claude; Deja, Maria; Brondani, Anita; Mehta, Sangeeta
Title: The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia
  • Document date: 2016_4_4
    • ID: krpg9u1u_47
    Snippet: Conservative fluid management during ARDS with the use of furosemide was associated with improved lung function and reduced duration of mechanical ventilation without increasing nonpulmonary organ failures [83] , although there was no significant difference in the primary outcome of 60-day mortality. Furthermore, a single-center study suggested that early treatment with hemofiltration as a rescue treatment for patients with ARDS may reduce cytoki.....
    Document: Conservative fluid management during ARDS with the use of furosemide was associated with improved lung function and reduced duration of mechanical ventilation without increasing nonpulmonary organ failures [83] , although there was no significant difference in the primary outcome of 60-day mortality. Furthermore, a single-center study suggested that early treatment with hemofiltration as a rescue treatment for patients with ARDS may reduce cytokine levels and systemic inflammatory response, improve cardiac function, and decrease extravascular lung water index, all of which were associated with improved outcomes [84] ; however, larger trials are needed. A 65-patient single-center trial published in Chinese found that patients randomized to continuous high-volume hemofiltration had better oxygenation, reduced duration of mechanical ventilation, and improved survival compared with standard care [85] .

    Search related documents:
    Co phrase search for related documents
    • conservative ARDS fluid management and mortality primary outcome: 1
    • conservative ARDS fluid management and organ failure: 1, 2
    • conservative ARDS fluid management and primary outcome: 1
    • conservative ARDS fluid management and standard care: 1
    • cytokine level and early treatment: 1
    • cytokine level and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • cytokine level and lung function: 1, 2
    • cytokine level and mechanical ventilation: 1, 2
    • cytokine level and mortality primary outcome: 1
    • cytokine level and organ failure: 1, 2, 3, 4, 5, 6
    • cytokine level and primary outcome: 1, 2, 3
    • cytokine level and significant difference: 1, 2, 3, 4, 5
    • cytokine level and single center: 1
    • cytokine level and single center study: 1
    • cytokine level and single center trial: 1
    • cytokine level and systemic inflammatory response: 1
    • early treatment and fluid management: 1, 2, 3, 4, 5, 6
    • early treatment and high volume: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • early treatment and high volume hemofiltration: 1